Mitochondrial respiratory chain disorders and the liver

Liver

Volumn 19, Issue 5, 1999, Pages 357-368

  Morris, Andrew A M ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Alpers syndrome; Hypoglycaemia; MtDNA depletion syndrome; Pearson syndrome; Progressive neuronal degeneration of childhood

Indexed keywords

ASCORBIC ACID; CELL NUCLEUS DNA; DICHLOROACETIC ACID; GLUCOSE; LACTIC ACID; MENADIONE; MITOCHONDRIAL DNA; RIBOFLAVIN; VALPROIC ACID;

BIOCHEMISTRY; BRAIN DISEASE; CLINICAL TRIAL; DIAGNOSTIC APPROACH ROUTE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EPILEPSY; FATTY LIVER; GENE REARRANGEMENT; GENETIC COUNSELING; HISTOCHEMISTRY; HISTOLOGY; HUMAN; HYPOGLYCEMIA; INTRAHEPATIC CHOLESTASIS; KIDNEY TUBULE DISORDER; LACTIC ACIDEMIA; LIVER CELL; LIVER FAILURE; LIVER FIBROSIS; LIVER TRANSPLANTATION; MUSCLE DISEASE; NERVE DEGENERATION; NEUROLOGIC DISEASE; PEARSON SYNDROME; POINT MUTATION; PRENATAL DIAGNOSIS; RESPIRATORY CHAIN; REVIEW;

DIFFUSE CEREBRAL SCLEROSIS OF SCHILDER; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT; HUMANS; HYPOGLYCEMIA; LACTIC ACID; LIVER; LIVER DISEASES; MITOCHONDRIA, LIVER; MITOCHONDRIA, MUSCLE; MITOCHONDRIAL MYOPATHIES;

EID: 0032860678     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.1999.tb00063.x     Document Type: Review

References (77)

1. SARASTE M. Oxidative phosphorylation at the fin de siecle. Science 1999; 283: 1488-93.
2. GRAY M W, BURGER G, LANG B F. Mitochondrial evolution. Science 1999; 283: 1476-81.
3. LARSSON N-G, CLAYTON D A. Molecular genetic aspects of human mitochondrial disorders. Annu Rev Genet 1995; 29: 157-78.
4. CHOMYN A. The myoclonic epilepsy and ragged-red fiber mutation provides new insights into human mitochondrial function and genetics. Am J Hum Genet 1998; 62: 745-51.
5. WATMOUGH N J, BINDOFF L A, BIRCH-MACHIN M A, et al. Impaired mitochondrial beta-oxidation in a patient with an abnormality of the respiratory chain. Studies in skeletal muscle mitochondria. J Clin Invest 1990; 85: 177-84.
6. 31P NMR examination of two patients with NADH-CoQ reductase deficiency. Nature 1982; 295: 608-9.
7. MELOV S, SCHNEIDER J A, DAY B J, et al. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat Genet 1998; 18: 159-63.
8. SOKOL R J, TWEDT D, MCKIM J M, et al. Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis. Gastroenterology 1994; 107: 1788-98.
9. MANSOURI A, GAOU I, FROMENTY B, et al. Premature oxidative aging of hepatic mitochondrial DNA in Wilson's disease. Gastroenterology 1997; 113: 599-605.
10. FROMENTY B, GRIMBERT S, MANSOURI A, et al. Hepatic mitochondrial DNA deletion in alcoholics: association with microvesicular steatosis. Gastroenterology 1995; 108: 193-200.
11. MCKENZIE R, FRIED M W, SALLIE R, et al. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N Engl J Med 1995; 333: 1099-105.
12. TREEM W R, SOKOL R J. Disorders of the mitochondria. Semin Liver Dis 1998; 38: 237-54.
13. FAYON M, LAMIREAU T, BIOULAC-SAGE P, et al. Fatal neonatal liver failure and mitochondrial cytopathy: an observation with antenatal ascites. Gastroenterology 1992; 103: 1332-5.
14. CORMIER-DAIRE V, CHRETIEN D, RUSTIN P, et al. Neonatal and delayed-onset liver involvement in disorders of oxidative phosphorylation. J Pediatr 1997: 130: 817-22.
15. GONCALVES I, HERMANS D, CHRETIEN D, et al. Mitochondrial respiratory chain defect: a new etiology for neonatal cholestasis and early liver insufficiency. J Hepatol 1995; 23: 290-4.
16. CORMIER V, RUSTIN P, BONNEFONT J-P, et al. Hepatic failure in disorders of oxidative phosphorylation of neonatal onset. J Pediatr 1991; 119: 951-4.
17. PARROT-ROULAUD F, CARRE M, LAMIRAU T et al. Fatal neonatal hepatocellular deficiency with lactic acidosis: a defect of the respiratory chain. J Inherit Metab Dis 1991; 14: 289-92.
18. MORRIS A A, TAYLOR R W, BIRCH-MACHIN M A, et al. Neonatal Fanconi syndrome due to deficiency of complex III of the respiratory chain. Pediatr Nephrol 1995; 9: 407-11.
19. RÖTIG A, BOURGERON T, CHRETIEN D, et al. Spectrum of mitochondrial DNA deletions in the Pearson marrow-pancreas syndrome. Hum Mol Genet 1995; 4: 1327-30.
20. MORRIS A A, TAANMAN J W, BLAKE J, et al. Liver failure associated with mitochondrial DNA depletion. J Hepatol 1998; 28: 556-63.
21. FRECKMANN M-L, THORBURN D R, KIRBY D M, et al. Mitochondrial electron transport chain defect presenting as hypoglycaemia. J Pediatr 1997; 130: 431-6.
22. NAVIAUX R K, NYHAN W L, BARSHOP B A, et al. Mitochondrial DNA polymerase γ deficiency and mtDNA depletion in a child with Alpers syndrome. Ann Neurol 1999; 45: 54-8.
23. MAASWINKEL-MOOIJ P D, VAN DEN BOGERT C, SCHOLTE H R, et al. Depletion of mitochondrial DNA in the liver of a patient with lactic acidemia and hypoketotic hypoglycemia. J Pediatr 1996; 128: 679-83.
24. CORMIER-DAIRE V, BONNEFONT J-P, RUSTIN P, et al. Mitochondrial rearrangements with onset as chronic diarrhea with villous atrophy. J Pediatr 1994; 124: 63-70.
25. RÖTIG A, CORMIER V, BLANCHE S, et al. Pearson's marrow-pancreas syndrome, a multisystem mitochondrial disorder in infancy. J Clin Invest 1990; 86: 1601-8.
26. HARDING B H. Progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher Syndrome): a personal review. J Child Neurol 1990; 5: 273-87.
27. BICKNESE A R, MAY W, HICKEY W F, DODSON W E. Early childhood hepatocerebral degeneration misdiagnosed as valproate hepatoxicity. Ann Neurol 1992; 32: 767-75.
28. 3, depletion is the cause of the deficient mitochondrial respiration induced by chronic valproate administration. Biochem Pharmacol 1992; 43: 644-7.
29. BIOULAC-SAGE P, PARROT-ROULAUD F, MAZAT J P, et al. Fatal neonatal liver failure and mitochondrial cytopathy (oxidative phosphorylation deficiency): a light and electron microscopic study of the liver. Hepatology 1993; 18: 839-46.
30. BOUSTANY R N, APRILLE J R, HALPERIN J, et al. Mitochondrial cytochrome deficiency presenting as a myopathy with hypotonia, external ophthalmoplegia and lactic acidosis in an infant and as fatal hepatopathy in a second cousin. Ann Neurol 1983; 14: 462-70.
31. BARKER H D, SCHOLTE H R, DINGEMANS K P, et al. Depletion of mitochondrial DNA in a family with fatal neonatal liver disease. J Pediatr 1996; 128: 683-7.
32. PEARSON H, LOBEL J, KOCOSHIS S, et al. A new syndrome of refractory sideroblastic anaemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr 1979; 95: 976-984.
33. DIMMICK J E, JEVON G P. Liver disease in the perinatal infant. In: Wiggleworth J S, Singer D B eds. Textbook of fetal and perinatal pathology. Oxford: Blackwell, 1998: 865-99.
34. CASARI G, DE Fusco M, CIARMATORI S, et al. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 1998; 93: 973-83.
35. LARSSON N G, HOLME E, KRISTIANSSON B, et al. Progressive increase of the mutated mitochondrial DNA fraction in Kearns-Sayre syndrome. Pediatr Res 1990; 28: 131-6.
36. MCSHANE M A, HAMMANS S R, SWEENEY M, et al. Pearson Syndrome and mitochondrial encephalomyopathy in a patient with a deletion of mtDNA. Am J Hum Genet 1991; 48: 39-42.
37. RöTIG A, BESSIS J-L, ROMERO N, et al. Maternally inherited duplication of the mitochondrial genome in a syndrome of proximal tubulopathy, diabetes mellitus and cerebellar ataxia. Am J Hum Genet 1992; 50: 364-70.
38. RÖTIG A, CORMIER V, CHATELAIN P. Deletion of mitochondrial DNA in a case of early onset diabetes mellitus, optic atrophy, and deafness (Wolfram syndrome, MIM 2223000). J Clin Invest 1993; 91: 1095-8.
39. MORRIS A A, LAMONT P J, CLAYTON P T. Pearson's syndrome without marrow involvement. Arch Dis Child 1997; 77: 56-7.
40. MORAES C T, SHANSKE S, TRISCHLER H-J, et al. mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet 1991; 48: 492-501.
41. TRITSCHLER H J, ANDREETTA F, MORAES C T, et al. Mitochondrial myopathy of childhood associated with depletion of mitochondrial DNA. Neurology 1992; 42: 209-17.
42. TAANMAN J W, BODNAR A G, COOPER J M, et al. Molecular mechanisms in mitochondrial DNA depletion syndrome. Hum Mol Genet 1997; 6: 935-42.
43. MAZZIOTTA M R, RICCI E, BERTINI E, et al. Fatal infantile liver failure associated with mitochondrial DNA depletion. J Pediatr 1992; 121: 896-901.
44. BAKKER H D, VAN DEN BOGERT C, SCHOLTE H R, et al. Fatal neonatal liver failure and depletion of mitochondrial DNA in three children of one family. J Inherit Metab Dis 1996; 19: 112-4.
45. LARSSON N G, OLDFORS A, HOLME E, CLAYTON D A. Low levels of mitochondrial transcription factor A in mitochondrial DNA depletion. Biochem Biophys Res Commun 1994; 200: 1374-81.
46. BODNAR A G, COOPER J M, HOLT I J, et al. Nuclear complementation restores mtDNA levels in cultured cells from a patient with mtDNA depletion. Am J Hum Genet 1993; 53: 663-9.
47. VON KLEIST-RETZOW J-C, CORMIER-DAIRE V, DE LONLAY P, et al. A high rate (20-30%) of parental consanguinity in cytochrome oxidase activity. Am J Hum Genet 1998; 63: 428-35.
48. VAN DER HEUVEL L, RUITENBEEK W, SMEETS R, et al. Demonstration of a new pathogenic mutation in human complex I deficiency: a 5-bp duplication in the nuclear gene encoding the 18-kD (AQDQ) subunit. Am J Hum Genet 1998; 62: 262-8.
49. BOURGERON T, RUSTIN P, CHRETIEN D, et al. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet. 1995; 11: 144-9.
50. ZHU Z, YAO J, JOHNS T, et al. SURF1, encoding a factor involved in the biogenesis of cytochrome oxidase, is mutated in Leigh syndrome. Nat Genet 1998; 20: 337-43.
51. MORIN C, MITCHELL G, LAROCHELLE J, et al. Clinical, metabolic, and genetic aspects of cytochrome C oxidase deficiency in Saguenay-Lac-Saint-Jean. Am J Hum Genet 1993; 53: 488-96.
52. MERANTE F, PETROVA-BENEDICT R, MACKAY N, et al. A biochemically distinct form of cytochrome oxidase (COX) deficiency in the Saguenay-Lac-Saint-Jean region of Quebec. Am J Hum Genet 1993; 53: 481-7.
53. ALPERS B J. Diffuse progressive degeneration of the gray matter of the cerebrum. Arch Neurol Psychiatry 1931; 25: 469-505.
54. HUTTENLOCHER P R, SOLITARE G B, ADAMS G. Infantile diffuse cerebral degeneration with hepatic cirrhosis. Arch Neurol 1976; 33: 186-92.
55. NARKEWICZ M R, SOKOL R J, BECKWITH B, et al. Liver involvement in Alpers Disease. J Pediatr 1991; 119: 260-7.
56. HARDING B N, ALSANJARI N, SMITH S J M, et al. Progressive neuronal degeneration of childhood with liver disease (Alpers' disease) presenting in young adults. J Neurol Neurosurg Psychiatry 1994; 58: 320-5.
57. MORRIS A A, SINGH-KLER R, PERRY R H, et al. Respiratory chain dysfunction in progressive neuronal degeneration of childhood with liver disease. J Child Neurol 1996; 11: 417-9.
58. PRICK M J J, GABREELS F J M, REINER W O, et al. Progressive infantile poliodystrophy, association with disturbed pyruvate oxidation in muscle and liver. Arch Neurol 1981; 38: 767-72.
59. TULINIUS M H, HOLME E, KRISTIANSSON B, et al. Mitochondrial encephalomyopathies in childhood. 2 clinical manifestations and syndromes. J Pediatr 1991; 119: 251-9.
60. PETERS H, CHOW C W, KIRBY D, et al. Respiratory chain complex I and other defects in Alpers disease. J Inherit Metab Dis 1998; 21: 75.
61. EDERY P, GERARD B, CHRETIEN D, et al. Liver cytochrome c oxidase deficiency in a case of neonatal-onset hepatic failure. Eur J Pediatr 1994; 153: 190-4.
62. RUSTIN P, CHRETIEN D, BOURGERON T, et al. Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 1994; 228: 35-51.
63. TRIJBELS J M F, SCHOLTE H R, RUITENBEEK W, et al. Problems with the biochemical diagnosis in mitochondrial (encephalo-) myopathies. Eur J Pediatr 1993; 152: 178-84.
64. JOHNSON M A, BINDOFF L A, TURNBULL D M. Cytochrome c oxidase activity in single muscle fibres: assay techniques and diagnostic applications. Ann Neurol 1993; 33: 28-35.
65. MORRIS A A, LEONARD J V. The treatment of congenital lactic acidoses. J Inherit Metab Dis 1996; 19: 573-80.
66. OGASAHAWA S, ENGEL A G, FRENS D, MACK D. Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci U S A 1989; 86: 2379-82.
67. 10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease. Neurology 1993; 43: 884-90.
68. BERNSEN P L, GABREELS F J, RUITENBEEK W, HAMBURGER H L. Treatment of complex I deficiency with riboflavin. J Neurol Sci 1993; 118: 181-7.
69. 3 and C in a patient with a defect in electron transport at complex III in skeletal muscle. Proc Natl Acad Sci U S A 1984; 81: 3529-33.
70. DE STEFANO N, MATTHEWS P M, FORD B, et al. Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders. Neurology 1995; 45: 1193-8.
71. THOMSON M, MCKIERNAN P, BUCKELS J, et al. Generalised mitochondrial cytopathy is an absolute contraindication to orthotopic liver transplantation. J Pediatr Gastroenterol Nutr 1998; 26: 478-81.
72. BERNES S M, BACINO C, PREZANT T R, et al. Identical mitochondrial DNA deletion in mother with progressive external ophthalmoplegia and son with Pearson marrow-pancreas syndrome. J Pediatr 1993; 123: 598-602.
73. BLAKE J C, TAANMAN J-W, MORRIS A A, et al. Mitochondrial DNA depletion syndrome is expressed in amniotic fluid cell cultures. Am J Pathol (In Press).
74. WANDERS R J A, RUITER J P N, WIJBURG F A, et al. Prenatal diagnosis of systemic disorders of the respiratory chain in cultured chorionic villus fibroblasts by study of ATP-synthesis in digitonin permeabilised cells. J Inherit Metab Dis 1996; 19: 133-6.
75. BLOK R B, GOOK D A, THORBURN D R, DAHL H-H M. Skewed segregation of the mtDNA nt 8993 (T to G) mutation in human oocytes. Am J Hum Genet 1997; 60: 1495-1501.
76. 8993 T-G disease. Am J Hum Genet 1992; 50: 629-33.
77. POULTON J, MACAULAY V, MARCHINGTON D R. Is the bottleneck cracked? Am J Hum Genet 1998; 62: 752-7.